SUMMARY. Egyptian geese (Alopochen aegypticus), a duck species endemic to sub-Saharan Africa and occasionally implicated in the transmission of avian influenza viruses (AIV) to farmed ostriches, were experimentally infected with low pathogenicity H7N1 and H6N8 viruses to assess viral shedding and immune profiles. Following the first infection with H7N1 virus, high titers of virus were shed from both the tracheae and cloacae for at least 7 days postinfection, and tracheal shedding lasting until day 14. All detectable shedding from both tracheae and cloacae had ceased within 28 days of infection. Antibody titers peaked at day 7 postinfection, but the initial immune response was short-lived. Birds that received a second challenge with the homologous H7N1 virus mounted a more robust response that lasted beyond 66 days postchallenge, and H7N1 virus was detected, albeit at much lower levels, until day 28 post secondary infection (psi) in the cloaca and beyond day 28 psi in the trachea. Birds that received an initial infection with H7N1 virus were also challenged with H6N8 virus, and because a comparable shedding pattern to the H7N1 challenge group was observed, we concluded that the effect of any nonspecific immunity was negligible.
Avian influenza (AI) is an infectious disease of birds, and occasionally mammals, caused by Type A influenza viruses. Avian influenza virus (AIV) serotypes are determined by two viral surface glycoproteins, viz., the hemagglutinin (HA) antigen, of which 16 subtypes are currently described, and the neuraminidase (NA) antigen, of which nine subtypes are known (11, 14, 16) . Domestic poultry infected with any of the AIV serotypes show replication only within the respiratory or digestive tract, and experience no or very mild disease (termed low pathogenicity avian influenza; LPAI). However, viruses of the H5 and H7 serotypes can mutate to the highly pathogenic form (HPNAI, where N refers to notifiable), producing a systemic infection and serious, highly contagious disease. HPNAI not only causes great economic losses but also has zoonotic potential (12).
Most HA and NA antigen combinations have been isolated from over 105 avian species, representing more than 26 families of aquatic birds (9) . Wild aquatic birds are considered the natural AIV reservoir, and maintain a continuously reassorting AIV population. Wild aquatic birds do not develop clinical signs or produce marked antibody responses to infection with LPAI viruses, and the viruses appear to be in a state of evolutionary stasis in these hosts (9, 10, 11, 14, 16) .
AI viruses replicate in both the cells of the respiratory and the gastrointestinal tracts of aquatic birds, but have long been reported to favor the gastrointestinal tract, because many more viruses have been isolated from the latter in studies of wild mallards (Anas platyrhynchos) in the northern hemisphere. Reports have concluded D Corresponding author. E-mail: abolnikc@arc.agric.za AVIAN DISEASES 56:341-346, 2012 that high concentrations of virus are excreted in feces into the environment, and other birds are consequently infected through ingestion (10, 14, 17) . Other studies aimed at experimentally determining the viral shedding profiles and immune responses of domestic ducks to infection with AIVs found that viral shedding peaked at day 2 to day 4 postinfection and lasted up to 14 days, with antibody responses lasting 21 days (13) . In contrast, in a study where two HPAI strains were used to infect Pekin ducks (Anas peking) viral shedding was only detected on days 1-5 postinfection (3). Kida et al. (10) experimentally inoculated Pekin ducks with LPAI H7N2, H4N1, H3N2, H1N1 strains, and detectable shedding of virus in faeces did not exceed 21 days postinfection.
Outbreaks of HPNAI H5N2 affected farmed ostriches in South Africa in 2004, 2006 , and 2011. These outbreaks were not epidemiologically associated, but phylogenetic analyses determined that the ostrich outbreak virus genes were similar to those isolated from wild ducks in the southern African region (1, C. Abolnik, unpublished laboratory data). The link between ostrich AIV outbreaks and regional wild duck viruses is not surprising, because wild birds frequently associate with the ostriches, attracted to the camps and irrigated pastures by a perennial source of food and water in an otherwise arid region. Egyptian geese (Alopochen aegyptiacus), large ducks endemic to southern Africa, are abundant in the Klein Karoo region of the Western Cape Province where most outbreaks occur. The Egyptian goose achieved the highest AIV risk score in a study that assessed 16 local duck species based on range, abundance, mobility, roost, mixed flocks, foraging, and anthropogenic association (6) . Frequency of contact between Egyptian geese and ostriches in the Klein Karoo region has also been proposed as a key factor for increased risk of farm-level H5 AI seropositivity (15) . In support of the aforementioned predictions, H10N9, H4N2, and H1N8 viruses have been isolated from Egyptian geese in South Africa since 1998 (2) , and in a recent survey of southern African wild birds, 7 out of 125 (5.6%) of AIV positive swabs were collected from Egyptian geese, 1 of 35 species tested (5) . Egyptian geese are thus important sentinels for AIV in the wild duck population in poultry-producing areas, especially ostriches.
Wild birds in the southern African region appear to behave opportunistically to environmental drivers (e.g., rainfall patterns, cultivated crop food availability); thus the ecology of avian influenza in wild duck populations appears much more complex than in the northern hemisphere, where there is a predictable annual cycle of virus circulation and strong seasonal variation in wild bird behaviors (5) . This unpredictability complicates targeted surveillance, and there is also increasing evidence that LPAI shedding varies between duck species (4) . In this study, we investigated the viral shedding and immune responses of Egyptian geese to challenge with a LPAI strain (H7N1) and a heterologous H6N8 virus.
MATERIALS AND METHODS
Viruses. Strains A/ostrich/South Africa/1991 (H7N1) and A/ostrich/ South Africa/KK98/1998 (H6N8) were propagated in embryonating fowls' eggs. Infective alantoic fluids were provided to the University of Pretoria for further passage and determination of the EID 50 titers. The infectivity titers were determined to be 10 7.8 EID 50 /ml and 10 8.2 EID 50 / ml for the H7N1 and H6N8 virus, respectively, these alantoic fluids were aliquotted and stored at 280 C until use.
Birds. Six Egyptian geese of both sexes and approximately 2-3 mo in age were purchased from a local breeder, under permit from the Gauteng Department of Nature Conservation. Birds were housed in a double-fence, access-controlled mesh cage (6 3 8 m) with a layer of activated lime laid inside the perimeter fence. Birds were provided with fresh drinking water and feed (chicken layer mash and lucern pellets) ad libitum, a pond, and fresh grass or lucern at least once a week. Individuals were individually identified with the use of leg rings. The protocol for this experimental trial was approved by the ARCOnderstepoort Animal Ethics Committee. Before the experiment commenced, birds were tested for AIV-specific antibodies and viral shedding by the methods described below, and were shown to be specific antibody free, and free of AIV infection. Birds were humanely euthanatized at the end of the experiment.
Primary infection with H7N1. All six birds were infected intranasally with 10 7.8 EID 50 /bird of the H7N1 virus in alantoic fluid. Determination of the infection titer and route was based on similar studies (3, 10, 13) . Tracheal and cloacal swabs were collected separately into 1-ml of viral transport medium (1:1 glycerol and phosphatebuffered saline with penicillin/streptomycin/mycostatin) on day 0 (preinfection), 1, 2, 3, 4, 5, 6, 7, 14, 21, 28, and 42 postinfection. Blood samples (0.5-1 ml) were collected from the alar veins of each bird on day 0 (preinfection), 7, 14, 21, 28, and 42 postinfection. Serum and swab samples were stored at 280 C until testing.
Secondary infection with H7N1 or H6N8. Birds were randomly allocated into two groups: Group 1 received a second challenge with H7N1 virus of 10 7.8 EID 50 /bird as before. Group 2 were challenged with 10 8.2 EID 50 /bird of H6N8 virus. Tracheal and cloacal swabs were collected on days 1-4 post secondary infection (psi); thereafter days 7, 14, 21, 28, 56 and 66 psi. Blood samples were collected as before on days 7, 14, 21, 28, 56, and 66 psi. Samples were stored at 280 C until testing.
RNA extraction and real-time RT-PCR. RNAs were extracted from the swab fluids with the use of TriZOLH reagent (Invitrogen Corporation, Carlsbad, CA) according to the manufacturer's recommended procedure. Viral titers were determined with the use of VLA TaqManH Influenza A and H7 Detection Kits (Applied Biosystems, Foster City, CA) according to the recommended procedure with the use of a Roche LightCycler 480 platform. A standard curve was generated based on a tenfold serial dilution (up to 10
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) of the H7N1 RNA to determine the relative viral titers. Viral RNA was still detectable at the lowest dilution. Cycle counts (Ct) from the real-time PCR assays were converted to EID 50 titers with the use of the standard curve (data not shown).
Enzyme-linked immunosorbent assay (ELISA). Two commercial ELISA tests were employed according to their recommended protocols: the FlockChek Avian Influenza Virus Antibody Test Kit (IDEXX Laboratories, Inc., Westbrook, ME) detects AIV-group antibodies, and the ID Screen Influenza H7 Antibody Competition ELISA (IDVET, Montpellier, France) specifically detects anti-H7 antibodies. Results for the IDEXX assay (sera of both groups) were interpreted by sample to negative control ratio (S/N). Samples with a S/N value $0.5 were considered negative and samples with S/N value ,0.5 were considered positive. For the IDVET assay (sera from Group 1 only), results were calculated as a competition percentage (competition %). Samples with a competition % #50 were considered positive, and samples with competition % .50 were considered negative. An ELx50 Auto Strip Washer and EL340 Microplate Bio Kinetic Reader (both from BioTek TM , Winooski, VT) were used. Hemagglutination inhibition (HI) assay. The HI assay was performed on sera of Group 2 according to standard OIE protocol (11) , with the use of the homologous A/ostrich/South Africa/KK98/ 1998 (H6N8) antigen. HI titers of 1:16 and above were considered to be positive.
Statistical analysis. Data were evaluated descriptively and presented as means and standard errors of the mean. Repeated-measures ANOVA models were used to determine if antibody titers and RT-PCR Ct varied over time and by treatment group (homologous versus heterologous AIV exposure). The effect of specimen source (trachea versus cloaca) was also estimated in the ANOVA model of RT-PCR results. Multiple pairwise post hoc tests were interpreted with the use of Bonferroni correction of unadjusted P values. Statistical modeling was performed with commercially available software (SPSS version 17.0, SPSS Inc., Chicago, IL), and results interpreted at the 5% level of significance. Serological results were dichotomized at the manufacturers' recommended cutoffs and proportion positive and exact 95% confidence intervals were calculated at each time point with another statistical program (Epi Info, version 6.04, CDC, Atlanta, GA).
RESULTS
Virus detection with the use of H7 real-time RT-PCR. High titers (Fig. 1 , average of 5.41 60 EID 50 ) were detected in the tracheal swabs collected on day 1 post initial infection (pii), but this declined slightly between day 2 and day 7 pii. The initial high viral titer detected at day 1 pii is probably due to viral particles present at the site of inoculation and not virus replication.
Viral titers in the tracheal swabs peaked on day 14 pii, and remained high for a further week, but by day 28 pii, virus shedding from the trachea had completely ceased and no virus was detectable in subsequent samples. Following the boost with H7N1 on day 49 (day 0 post secondary infection; psi), a small peak in tracheal viral shedding titer (average of 2.7 8 EID 50 ) was observed on day 1 psi, no shedding was detected on days 2 and 3 psi and virus was again detected from day 4 to at least day 21 psi, albeit at much lower titers compared to the primary inoculation. Unfortunately, the experiment concluded before the end point of viral shedding from the trachea.
Virus shed from the cloaca via the faeces was detected from day 2 pii onwards, peaking from days 4 to 7 pii, with an average titer of 2.7 47 EID 50 , comparable with the titers shed from the trachea during the same period. From day 14 pii onwards no virus was detected in the cloacal swabs. Following the second inoculation on day 49 (day 0 psi), cloacal virus titers showed a slight increase, as with the tracheal swabs, on day 1 psi. Again, virus was undetectable in the cloacal swabs on days 2 and 3 psi, but peaked at a titer of 3.97 13 EID 50 on day 4 psi, continuing until day 14 psi, but was undetectable on day 21 psi.
Group 1 birds (H7N1 initial infection; H7N1 secondary infection, Fig. 2 ) shed low titers (between 1.3 8 and 2.05 13 EID 50 ) from day 4 psi onwards, and virus was still detectable on day 28 (the experiment concluded before the end point was reached). H7 virus detected in the trachea at day 1 was probably due to RNA still present at the site of inoculation; however, in cloacal swabs from the same birds, low titers were also detected on day 1 psi, possibly representing passive transport of the initial inoculum. Shedding of H7 virus from the cloaca in low titers persisted until at least day 21 psi, but was undetectable at day 28 psi.
Group 2 birds (H7N1 initial infection, H6N8 secondary infection) shed high titers (from 1.75 63 until 3.51 54 EID 50 ) of H6N8 virus from day 3 psi onwards, and shedding continued beyond day 28 psi when the experiment ended. H6N8 shedding from the cloaca was detectable from day 4 psi, and similarly lasted beyond day 28.
Statistical analyses were applied to the rRT-PCR results: within homologous-challenged Egyptian geese a single combined analysis for both initial and booster infection showed no significant change in Ct by specimen (P 5 0.311), indicating no significant difference Low pathogenicity avian influenza virus infection of Egyptian geese in virus shedding between trachea and cloaca (P 5 0.688). There was however a significant effect of time (P 5 0.046) that varied by pre versus post challenge (P 5 0.001), indicating that the magnitude of shedding did not change but the pattern was different after the secondary challenge.
Within heterologous challenged birds, in a single combined analysis for both initial and booster infection, there was no significant change in Ct by specimen (P 5 0.053), but there was a significant effect of pre-versus postsecondary challenge (P 5 0.046). The effect of time was also significant (P 5 0.013) and varied by pre-versus postchallenge (P 5 0.008). This suggested that the magnitude and virus shedding pattern varied pre and postsecondary challenge.
Serological immune responses. The FlockChek Avian Influenza Virus Antibody Test Kit, ELISA (IDEXX) measures group-specific antibodies directed against an internal group-specific antigen (i.e., not a surface glycoprotein, thus not serotype-specific). For this reason, the average serological data for all six birds are presented in Fig. 3 . Influenza A antibody titers peaked at day 7 pii (S/N ratio of 0.327), were still positive at day 14 pii (S/N ratio of 0.39), but had dropped below the positive threshold by day 21 pii (S/N ratio of 0.50). There was a significant change in S/N over time (P , 0.001) but these values were not different for birds that subsequently received the different booster challenges (P 5 0.434; Table 1 ). The booster effect was visible a week after the second infection (at day 7 psi), with average antibody titers peaking on day 14 psi (S/N ratio of 0.20). By day 56 psi AIV-specific antibody titers were still positive (S/N ratio of 0.42), but by day 66 psi had dropped below the threshold for positivity (S/N ratio of 0.61). After the second infection there was again a significant change in S/N over time (P , 0.001) that was not different between groups (P 5 0.789). The proportion of positive classifications also did not appear to vary between the two challenge groups.
Sera from Group 1 birds (H7N1 primary and secondary infection) were tested with the ID Screen Influenza H7 Antibody Competition ELISA (IDVET). Results (Fig. 3) were generally comparable to the IDEXX group-specific assay: anti-H7 serotype antibodies were above the positive threshold at day 7 pii (competition % of 44.07), but had dropped below the threshold before day 14 pii (competition % of 54.34). There was a significant change in competition % over time (P , 0.001) that was not different between groups (P 5 0.914). Following the secondary infection with homologous H7N1 virus, anti-H7 antibodies peaked from days 7 to 14 psi (competition % from 7.9 to 6.0), and showed a decline, but were still positive at day 66 psi (competition % of 40.21). After the second challenge there was a significant change in Table 1 . Proportion positive (95% confidence interval) ELISA results for all birds after primary infection with H7N1 virus and secondary infection with H7N1 and H6N8. competition % over time (P , 0.001) that varied by treatment group. None of the birds receiving secondary inoculation with heterologous H6N8 virus were positive with this H7 specific kit (Table 1) . Unfortunately, the experiment concluded before the endpoint of detection for H7 antibodies was reached.
Hemagglutination inhibition (HI). H6N8-specific antibody HI titers were only detected in a single bird from Group 2, on day 14 (1:16), day 21 psi (1:32) day 28 psi (1:8), and day 56 psi (1:16) . No clinical signs were observed in any bird during the study.
DISCUSSION
Our results indicate that following primary infection, all birds shed high quantities of H7N1 virus from both the trachea and the gastrointestinal tracts soon after infection for at least seven days postinfection. Tracheal shedding appeared to last at least two weeks longer than cloacal shedding, and all shedding had ceased within 28 days of infection. These observations are in agreement with those of other studies (4, 12) .
Group 1 birds (primary and secondary infection with H7N1) shed H7N1 virus postsecondary infection from around day 4, albeit in much lower quantities from both the trachea and cloaca. Shedding from both the trachea and cloaca continued beyond the termination of the experiment 28 days later. Whether the low titers shed are sufficient to reinfect another bird was beyond the scope of this study. Cloacal shedding was not significantly different than tracheal, but tracheal shedding lasted two weeks longer descriptively, and the difference within challenged birds was close to the significance cutoff (P 5 0.053).
Group 2 birds (primary infection with H7N1, secondary infection with H6N8) shed high titers of H6N8 virus from both the trachea and cloaca, in a profile similar to that of the initial H7N1 infection (peak titer of 3.5 63 EID 50 on day 3 for cloacal swabs and 5.05 58 EID 50 on day 4 for tracheal swabs, compared to peak titers of 2.7 47 on day 7 pii for cloacal swabs and 5.57 61 on day 14 pii for tracheal swabs). Thus, we did not observe any nonspecific cross-protection between the heterologous subtypes, although this has been reported in other studies (4, 7) .
The immune responses to H7N1 challenge indicated a short-lived and weak initial response that peaked at 7 days post initial infection, followed by a much more rapid and robust response following a second infection with H7N1. Antibody titers peaked from day 7 to day 14 post secondary infection, and lasted just over 2 mo. Birds challenged with a heterologous H6N8 virus only mounted a low H6 antibody-specific immune response as assessed by HI assay using the homologous H6N8 antigen (peak titer of only 1:32 in only one bird) as might be expected for a primary exposure.
We report the first AIV shedding and immune profiles of an indigenous African duck that is frequently implicated in the transmission of potentially pathogenic influenza A viruses to farmed poultry, particularly ostriches in South Africa's case. These data are expected to aid in refining surveillance strategies, enabling a more effective early warning system for the presence of potentially pathogenic AIVs in the region. The longer duration and slightly higher titers of tracheal viral shedding compared to cloacal shedding implies that tracheal swabs are preferable to cloacal swabs, if it is not possible to collect both. This finding is in contrast to published reports that other ducks replicate AIVs preferentially in the gastrointestinal tract (10, 14, 17) . There was no significant difference in tracheal and cloacal shedding with the H7N1 virus used in this study, but we acknowledge that variations in site and levels of replication may vary with different AIV strains. Blood samples are usually not collected from wild ducks because of the induced stress, but based on our results AIV-group antibody titers indicate exposure to the virus within a 3-mo period, and this would be useful in identifying populations that are maintaining AIVs on a seasonal or perennial basis.
Juvenile Egyptian geese that are immunologically naive are expected to excrete the highest viral titers and should be targeted for surveillance. Published accounts from North America and Europe similarly found that the immunologically naïve juveniles migrating from their breeding sites are the birds who are most likely to shed and spread AIV (8) . However, our data also suggest that nonspecific cross-protecting immunity is limited, causing high titers of heterologous challenge strains being shed into the environment. Surveillance of adult geese for AIV thus remains a worthwhile initiative. Our findings also thus have implications for disease transmission models in Africa, e.g. (7), that have taken partial crossprotective immunity into account. Perhaps the lack of crossprotective immunity in this study was a function of the combination of strains we used (H7N1 3 H6N8), whereas different strains (H5N2 3 H3N8; H3N8 3 H5N2) were used in the studies where cross-protective immunity was reported (4) . More infection studies should be performed on a wider range of African bird species, with the use of a wider range of LPAI subtypes and combinations to refine surveillance strategies for the region further.
